相似文献
1
USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.
EMBO Rep. 2011 Sep 1;12(9):924-30. doi: 10.1038/embor.2011.140.
2
Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.
J Biol Chem. 2015 Sep 4;290(36):21996-2004. doi: 10.1074/jbc.M114.631663. Epub 2015 Jul 20.
3
Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination.
J Cell Physiol. 2015 Jul;230(7):1651-60. doi: 10.1002/jcp.24917.
4
Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
J Cell Physiol. 2017 Dec;232(12):3664-3676. doi: 10.1002/jcp.25841. Epub 2017 May 3.
5
USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A.
Cell Cycle. 2008 Jun 1;7(11):1522-4. doi: 10.4161/cc.7.11.5962. Epub 2008 Mar 18.
6
The tightly controlled deubiquitination activity of the human SAGA complex differentially modifies distinct gene regulatory elements.
Mol Cell Biol. 2011 Sep;31(18):3734-44. doi: 10.1128/MCB.05231-11. Epub 2011 Jul 11.
7
A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex.
Mol Cell Biol. 2013 Apr;33(8):1487-502. doi: 10.1128/MCB.00971-12. Epub 2013 Feb 4.
8
Far upstream element binding protein 1: a commander of transcription, translation and beyond.
Oncogene. 2013 Jun 13;32(24):2907-16. doi: 10.1038/onc.2012.350. Epub 2012 Aug 27.
9
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9298-E9307. doi: 10.1073/pnas.1807704115. Epub 2018 Sep 17.
10
Ubiquitin-specific peptidase 42 (USP42) functions to deubiquitylate histones and regulate transcriptional activity.
J Biol Chem. 2014 Dec 12;289(50):34862-70. doi: 10.1074/jbc.M114.589267. Epub 2014 Oct 21.
引用本文的文献
1
Bioinformatic analysis of the role of USP22 expression in hepatocellular carcinoma.
Int J Clin Exp Pathol. 2025 Jul 15;18(7):287-301. doi: 10.62347/FXIN5300. eCollection 2025.
2
USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity.
Clin Transl Med. 2025 May;15(5):e70324. doi: 10.1002/ctm2.70324.
3
Deubiquitinases as novel therapeutic targets for diseases.
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.
4
USP22 Promotes Osteosarcoma Progression by Stabilising β-Catenin and Upregulating HK2 and Glycolysis.
J Cell Mol Med. 2024 Dec;28(23):e70239. doi: 10.1111/jcmm.70239.
5
Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit.
Sci Adv. 2024 Aug 16;10(33):eado1533. doi: 10.1126/sciadv.ado1533.
6
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression.
Cell Death Discov. 2024 Mar 11;10(1):128. doi: 10.1038/s41420-024-01894-8.
7
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Cell Commun Signal. 2023 Nov 9;21(1):319. doi: 10.1186/s12964-023-01320-z.
8
Deubiquitinases in cancer.
Nat Rev Cancer. 2023 Dec;23(12):842-862. doi: 10.1038/s41568-023-00633-y. Epub 2023 Nov 7.
9
Usp22 Deficiency Leads to Downregulation of PD-L1 and Pathological Activation of CD8 T Cells and Causes Immunopathology in Response to Acute LCMV Infection.
Vaccines (Basel). 2023 Oct 5;11(10):1563. doi: 10.3390/vaccines11101563.
10
Deubiquitylating Enzymes in Cancer and Immunity.
Adv Sci (Weinh). 2023 Dec;10(36):e2303807. doi: 10.1002/advs.202303807. Epub 2023 Oct 27.
本文引用的文献
1
Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
J Gastroenterol Hepatol. 2010 Nov;25(11):1800-5. doi: 10.1111/j.1440-1746.2010.06352.x.
2
Molecular basis of FIR-mediated c-myc transcriptional control.
Nat Struct Mol Biol. 2010 Sep;17(9):1058-64. doi: 10.1038/nsmb.1883. Epub 2010 Aug 15.
3
Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance.
Mol Cell. 2009 Aug 14;35(3):352-64. doi: 10.1016/j.molcel.2009.06.015.
4
Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
Hepatology. 2009 Oct;50(4):1121-9. doi: 10.1002/hep.23098.
5
Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
Hepatology. 2009 Oct;50(4):1130-9. doi: 10.1002/hep.23051.
6
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies.
Cell. 2008 Aug 22;134(4):668-78. doi: 10.1016/j.cell.2008.07.039.
7
How the c-myc promoter works and why it sometimes does not.
J Natl Cancer Inst Monogr. 2008(39):41-3. doi: 10.1093/jncimonographs/lgn004.
8
HDAC4 promotes growth of colon cancer cells via repression of p21.
Mol Biol Cell. 2008 Oct;19(10):4062-75. doi: 10.1091/mbc.e08-02-0139. Epub 2008 Jul 16.
9
The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.
Mol Cell. 2008 Jan 18;29(1):102-11. doi: 10.1016/j.molcel.2007.12.015.
10
A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.
Mol Cell. 2008 Jan 18;29(1):92-101. doi: 10.1016/j.molcel.2007.12.011.
Zotero 插件